The future of organ transplantation: from the laboratory to the clinic

被引:8
作者
Calne, RY [1 ]
机构
[1] Univ Cambridge, Dept Surg, Cambridge CB2 2AH, England
关键词
tolerance; organ transplantation;
D O I
10.1098/rstb.2001.0848
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This is a short review of tolerance from the point of view of the clinician. Various examples of tolerance occurring in patients and animal models that relate to the clinical experience are described. It is suggested that there may be different mechanisms by which tolerance is achieved, but from the patient's point of view operational tolerance is the goal, whereby, after a short induction procedure, the patient will maintain good function in the grafted organ indefinitely without maintenance immunosuppression. It is pointed out that such a goal may be difficult to achieve with any given protocol due to the enormous variation between donors and recipients of organ grafts of tissue matching, innate immune reactivity and susceptibility to disturbance of a tolerant state by infections or allergic reactions. Thus the case is made for prope or almost tolerance in which graft acceptance is maintained by a low, non-toxic dosage of maintenance immunosuppression that may not be required indefinitely.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 26 条
[11]   RETRACTED: Peritransplant tolerance induction with anti-CD3-immunotoxin - A matter of proinflammatory cytokine control (Retracted article. See vol 85, pg. 920, 2008) [J].
Contreras, JL ;
Wang, PX ;
Eckhoff, DE ;
Lobashevsky, AL ;
Asiedu, C ;
Frenette, L ;
Robbin, ML ;
Hubbard, WJ ;
Cartner, S ;
Nadler, S ;
Cook, WJ ;
Sharff, J ;
Shiloach, J ;
Thomas, FT ;
Neville, DM ;
Thomas, JM .
TRANSPLANTATION, 1998, 65 (09) :1159-1169
[12]  
FRIEND PJ, 1995, TRANSPLANT P, V27, P869
[13]  
Gibson T, 1943, J ANAT, V77, P299
[14]  
HALE G, 1988, LANCET, V2, P1394
[15]  
HELG C, 1994, TRANSPLANTATION, V58, P1420
[16]   TOLERANCE TO AN HLA-B,DR DISPARATE KIDNEY ALLOGRAFT AFTER BONE-MARROW TRANSPLANTATION FROM SAME DONOR [J].
JACOBSEN, N ;
TAANING, E ;
LADEFOGED, J ;
KRISTENSEN, JK ;
PEDERSEN, FK .
LANCET, 1994, 343 (8900) :800-800
[17]   CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates [J].
Kirk, AD ;
Harlan, DM ;
Armstrong, NN ;
Davis, TA ;
Dong, YC ;
Gray, GS ;
Hong, XN ;
Thomas, D ;
Fechner, JH ;
Knechtle, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8789-8794
[18]  
KNECHTLE S, 1997, TRANSPLANTATION, V63, P4
[19]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497
[20]   PROLONGED SURVIVAL OF HUMAN-KIDNEY HOMOGRAFTS BY IMMUNOSUPPRESSIVE DRUG THERAPY [J].
MURRAY, JE ;
HARRISON, JH ;
DAMMIN, GJ ;
WILSON, RE ;
MERRILL, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1963, 268 (24) :1315-&